DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-2.56%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.41B
AUM Growth
+$2.41B
(+12%)
Cap. Flow
+$318M
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
37.73%
Holding
113
New
19
Increased
14
Reduced
20
Closed
12
Top Buys
| 1 |
Elevance Health
ELV
|
$45.7M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$45.6M |
| 3 |
LCI
Lannett Company, Inc.
LCI
|
$44.3M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$40.8M |
| 5 |
Centene
CNC
|
$34.1M |
Top Sells
| 1 |
DaVita
DVA
|
$23.1M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$22.1M |
| 3 |
Select Medical
SEM
|
$18.3M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$17.5M |
| 5 |
AET
Aetna Inc
AET
|
$15.4M |
Sector Composition
| 1 | Healthcare | 69.82% |
| 2 | Financials | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $145M | 5.96% | 8,956,988 +2,522,549 | +39% | +$40.8M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $112M | 4.59% | 4,258,196 +159,021 | +4% | +$4.17M |
|
|
AVXS
3
DELISTED
AveXis, Inc. Common Stock
AVXS
| $107M | 4.39% | 2,236,701 | – | – |
|
|
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $104M | 4.3% | 4,654,447 -985,280 | -17% | -$22.1M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $104M | 4.27% | 928,192 -80,283 | -8% | -$8.97M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $69.6M | 2.86% | 1,838,829 +500,000 | +37% | +$18.9M |
|
7
Viatris
VTRS
$12.3B
| $67.4M | 2.77% | 1,766,378 +343,044 | +24% | +$13.1M |
|
|
DBVT
8
DBV Technologies
DBVT
$264M
| $61.2M | 2.52% | 1,743,229 | – | – |
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $54.6M | 2.25% | 3,424,676 -10,900 | -0.3% | -$174K |
|
|
NVRO
10
DELISTED
NEVRO CORP.
NVRO
| $54.6M | 2.25% | 751,298 +214,943 | +40% | +$15.6M |
|
11
Xencor
XNCR
$580M
| $53.2M | 2.19% | 2,020,000 -190,900 | -9% | -$5.02M |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $51.7M | 2.13% | 1,842,415 +1,626,829 | +755% | +$45.6M |
|
|
13
Elevance Health
ELV
$71.8B
| $45.7M | 1.88% | +318,000 | New | +$45.7M |
|
|
LCI
14
DELISTED
Lannett Company, Inc.
LCI
| $44.3M | 1.82% | +2,007,551 | New | +$44.3M |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.43B
| $42.3M | 1.74% | 4,072,809 | – | – |
|
16
Humana
HUM
$36.5B
| $40.4M | 1.66% | 198,000 +38,500 | +24% | +$7.86M |
|
|
UAM
17
DELISTED
Universal American Corp
UAM
| $37.6M | 1.55% | 3,774,090 -817,970 | -18% | -$8.14M |
|
|
18
Centene
CNC
$14.3B
| $34.1M | 1.4% | +603,643 | New | +$34.1M |
|
|
AET
19
DELISTED
Aetna Inc
AET
| $30M | 1.23% | 242,000 -124,000 | -34% | -$15.4M |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $29.5M | 1.21% | 355,957 | – | – |
|
21
eHealth
EHTH
$118M
| $28.1M | 1.16% | 2,640,609 | – | – |
|
22
Editas Medicine
EDIT
$231M
| $27.7M | 1.14% | 1,709,400 | – | – |
|
23
Galapagos
GLPG
$2.07B
| $27.2M | 1.12% | 423,112 | – | – |
|
24
Globus Medical
GMED
$8.27B
| $25.7M | 1.06% | +1,036,000 | New | +$25.7M |
|
|
BOLD
25
DELISTED
Audentes Therapeutics, Inc
BOLD
| $25.6M | 1.06% | 1,403,653 | – | – |
|